With recent questions about AstraZeneca’s product, Macau and Hong Kong are unwilling to take any risks with Covid-19 vaccines. The two territories announced on Wednesday the suspension of their vaccination campaign with the Pfizer-BioNTech vaccine after being informed by the laboratory of a problem with the packaging of a batch of vials.
“As a precautionary principle, the current vaccination must be suspended for the duration of the investigation,” said the Hong Kong executive. Macao and Hong Kong said they made the decision after being contacted by Fosun, the Chinese pharmaceutical company that distributes the Pfizer / BioNTech vaccine in China.
According to the authorities, the vials bearing the lot number 210102 showed a defective type of packaging. The press releases from the authorities of the two territories did not specify the nature of these defects but they underline that this does not present any risk in terms of health security.